COMPARISON OF THREE INTRAVENOUS BISPHOSPHONATES IN CANCER-ASSOCIATED HYPERCALCAEMIA

This publication has 17 references indexed in Scilit:

• Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents.
  Journal of Clinical Investigation, 1988
• THE PATHOGENESIS OF HUMORAL HYPERCALCAEMIA OF MALIGNANCY
  The Lancet, 1987
• Parathyroid Hormone-Related Protein of Malignancy: Active Synthetic Fragments
  Science, 1987
• Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride
  The American Journal of Medicine, 1987
• COMPARISON OF AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE, MITHRAMYCIN, AND CORTICOSTEROIDSICALCITONIN IN TREATMENT OF CANCER-ASSOCIATED HYPERCALCAEMIA
  The Lancet, 1985
• Intravenous etidronate in the management of malignant hypercalcemia
  Archives of internal medicine (1960), 1985
• Hypercalcaemia of Malignancy: Evidence for a Non-Parathyroid Humoral Agent with An Effect on Renal Tubular Handling of Calcium
  Clinical Science, 1984
• COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIA
  The Lancet, 1983
• Predictive Value of Derived Calcium Figures Based on the Measurement of Ionised Calcium
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1981
• NOMOGRAM FOR DERIVATION OF RENAL THRESHOLD PHOSPHATE CONCENTRATION
  The Lancet, 1975